Today, at a press conference in Kigali 🇷🇼, CEPI announced a new partnership with Rwanda-owned Akagera Medicines. The partnership will advance the development of Akagera Medicines' innovative lipid nanoparticles and modified mRNA technology. Learn more➡️bit.ly/3NuKtqI

Congratulations and a warm welcome to Dr Dr Sania Nishtar, the incoming CEO of @Gavi. I look forward to continuing @CEPIvaccine’s collaboration with @Gavi, under Dr Nishtar’s leadership, as we continue to drive forward our shared mission of ensuring equitable access to vaccines

Could a chrysalis-based ‘living bioreactor’ prove an innovative method for speeding up human vaccine production? Scientists in Spain are set to find out. bit.ly/4b35EKn Check out CEPI’s latest funding partnership to learn more ⬇️

What exactly is Disease X? With the concept of #DiseaseX at the heart of efforts to be better prepared for future pandemics, CEPI looks at what people most want to find out about this unknown pathogen. Check out our explainer blog to learn more ⬇️ cepi.net/news_cepi/dise…

Check out February's Updates & Insights ✨ From future-proofing vaccine production in Africa to advancing diagnostics for Nipah virus and Lassa fever, plus plenty more, this month's newsletter covers it all. linkedin.com/pulse/future-p…

Investing in vaccines is a ‘no-brainer’ Adam Tooze writes for the FT Weekend, reinforcing the ‘unbeatable’ cost-benefit ratio of investing in vaccines now to better prepare for a future Disease X threat. on.ft.com/3xdlUck

🔉CEPI statement in response to Pandemic Agreement negotiation extension🔉tinyurl.com/3s9xvzer "The COVID-19 pandemic was one of the most devastating global crises to face our civilization since World War 2. The tragic inequity in access to medical countermeasures that

H1N1, H2N2, H3N2: All belonging to the Orthomyxovirus family, these viruses have been behind some of the deadliest pandemics in human history. As these and other members of the Orthomyxovirus family—including #H5N1 bird flu—continue to pose a potential pandemic threat, learn

🔉 Speaker announcement for The Global Pandemic Preparedness Summit 2024, July 29-30. Ministério da Saúde 🩵, Fiocruz & CEPI are pleased to welcome Chikwe Ihekweazu, Assistant Director-General, World Health Organization (WHO), as an expert speaker at #GPPS2024. Check out other confirmed speakers ➡️cepi.net/gpps

Could #H5N1 develop into a fast-spreading human outbreak? Is the world ready to respond? Listen to experts Rick Bright, Dame Sarah Gilbert, Dr Nicole Lurie & more next week at #GPPS2024 to hear how we can prepare for an equitable 100-day response to a bird flu pandemic.

I am thrilled to announce that global health expert Aurélia Nguyen will be joining CEPI as our new Deputy CEO on October 1. Aurélia comes from Gavi, the Vaccine Alliance and brings a wealth of experience from both the multilateral and private sectors to what is going to be a critical role.

📣We are delighted to announce that Brazil’s Bio-Manguinhos/Fiocruz has joined CEPI’s network of vaccine manufacturers in the Global South, working to support faster and more equitable responses to future emerging infectious disease threats. cepi.net/mobilising-bra…

That’s a wrap on the Global Pandemic Preparedness Summit 2024 👏 The two-day summit, co-hosted by Ministério da Saúde 🩵, Fiocruz, and CEPI featured more than 20 sessions and 80 speakers, advancing critical conversations that will help better prepare the world for future pandemic threats.

.CEPI & WHO call for an expansion of pandemic research 🔬: focus on families of pathogens in addition to individual disease threats. This approach boosts readiness for unforeseen outbreaks, zoonotic spill-overs, and the hypothetical threat of a ‘pathogen X’: